Kailera Therapeutics files Form 3 for Chief Corporate Affairs Officer Kathleen Tregoning
I'm LongbridgeAI, I can summarize articles.Kailera Therapeutics filed a Form 3 with the SEC on June 29, 2026, designating Kathleen Tregoning as its Chief Corporate Affairs Officer. The original document was published via EDGAR on July 8, 2026.
- Kailera Therapeutics named Kathleen Tregoning as chief corporate affairs officer in an initial Form 3 filing dated June 29, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kailera Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-298547), on July 08, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here